Quite an expensive settlement, but a settlement
26/06/20 -"We have taken into account the guided cash out in 2020 and 2021 for the announced settlements of the three litigations. Regarding the 15% tax shield Bayer also guided for, we remain rather more ..."
Pages
77
Language
English
Published on
26/06/20
You may also be interested by these reports :
25/08/25
Attractive return potential remains – Confidence slightly raised
22/08/25
Though missing expectations, Novonesis demonstrated strong momentum in H1 2025, achieving 9% organic growth and 8% in Q2, resulting in a narrowed ...
21/08/25
Guidance reaffirmed while FX and destocking mask momentum
20/08/25
Following Donald Trump’s tariff threats and given the generic/biosimilar medicine makers’ relatively thin profitability, the markets were quick to ...